Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
about
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyChemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.Thiazolidinedione drugs promote onset, alter characteristics, and increase mortality of ischemic ventricular fibrillation in pigs.PPARγ and Its Role in Cardiovascular Diseases.
P2860
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@ast
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@en
type
label
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@ast
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@en
prefLabel
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@ast
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@en
P2860
P1476
Cardiac ion channel modulation by the hypoglycaemic agent rosiglitazone
@en
P2093
J C Hancox
P2860
P304
P356
10.1111/J.1476-5381.2011.01281.X
P407
P577
2011-06-01T00:00:00Z